{
    "data": [
        {
            "id": "67a25cc99d57a90001d505d7",
            "title": "Behind the Scenes of Apple&#39;s Latest Options Trends",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/movers_image_0.jpeg",
            "link": "https://www.benzinga.com/insights/options/25/02/43473693/behind-the-scenes-of-apples-latest-options-trends",
            "pub_date": "2025-02-05 02:30:36",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a25d119d57a90001d50618",
            "title": "Cumberland Pharmaceuticals&#39; Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease",
            "description": "Cumberland Pharmaceuticals&#39; Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/CPIX.png",
            "link": "https://www.benzinga.com/general/biotech/25/02/43473776/cumberland-pharmaceuticals-duchenne-candidate-shows-improved-heart-function-in-patients-with-associated-heart-disease",
            "pub_date": "2025-02-05 02:31:48",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a25daa9d57a90001d5064f",
            "title": "Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/cardinalhealth-Company.jpeg",
            "link": "https://www.benzinga.com/25/02/43473832/cardinal-health-analysts-raise-their-forecasts-following-upbeat-earnings-2",
            "pub_date": "2025-02-05 02:34:21",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a25b449d57a90001d50535",
            "title": "Nintendo Q3 Revenue Drops, Cuts Outlook and Dividend, Switch Sales Slow Ahead of Next-Gen Console",
            "description": "Nintendo&#39;s Q3 revenue decreased to 432.92 billion Japanese yen, with EPS at 110.40 Japanese yen. It sold 4.82 million Nintendo Switch units and lowered sales forecasts for fiscal 2025.",
            "image": "https://www.benzinga.com/files/images/story/2025/02/04/Nintendo-Switch.jpeg",
            "link": "https://www.benzinga.com/25/02/43473500/nintendo-q3-earnings-revenue-drops-cuts-outlook-and-dividend-switch-sales-slow-ahead-of-next-gen-console",
            "pub_date": "2025-02-05 02:24:07",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "67a2593a9d57a90001d5043b",
            "title": "How Is The Market Feeling About S&amp;P Global?",
            "description": " ",
            "image": "https://www.benzinga.com/files/images/story/2023/movers_image_18.jpeg",
            "link": "https://www.benzinga.com/insights/short-sellers/25/02/43473256/how-is-the-market-feeling-about-s-p-global",
            "pub_date": "2025-02-05 02:15:26",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}